Search result for 'schizophrenia'

Glenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and impurities. The USFDA has issued Class II and III recalls for medications like Propafenone,...

Glenmark and Biocon are recalling products in the US due to manufacturing issues. USFDA initiated Class II recalls for chlorpromazine hydrochloride tablets and a cholesterol medication.

Allchem Lifescience, an Indian API manufacturer, has filed IPO papers with Sebi to raise Rs 190 crore via a fresh issue and OFS. The company specializes in piperazine derivatives and caters to...

Alembic Pharmaceuticals has received USFDA approval for its generic version of Brexpiprazole tablets, used to treat major depressive disorder. The approval covers strengths ranging from 0.25 mg to...

Zydus Lifesciences has received USFDA approval to manufacture generic Paliperidone extended-release tablets, used to treat schizophrenia. The tablets will be produced at the company's Ahmedabad...

Alembic Pharmaceuticals receives USFDA approval for its generic version of Paliperidone extended-release tablets, indicated for treating schizophrenia. The drug is therapeutically equivalent to...

Asian shares mostly rose on Friday, driven by optimism about the US jobs report. The Nikkei 225 shed 1.8% as investors speculate about the Bank of Japan's policy. Read more.